Perturbation-specific transcriptional mapping for unbiased target elucidation of antibiotics
Open Access
- 28 October 2024
- journal article
- research article
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 121 (45)
Abstract
The rising prevalence of antibiotic resistance threatens human health. While more sophisticated strategies for antibiotic discovery are being developed, target elucidation of new chemical entities remains challenging. In the postgenomic era, expression profiling can play an important role in mechanism-of-action (MOA) prediction by reporting on the cellular response to perturbation. However, the broad application of transcriptomics has yet to fulfill its promise of transforming target elucidation due to challenges in identifying the most relevant, direct responses to target inhibition. We developed an unbiased strategy for MOA prediction, called perturbation-specific transcriptional mapping (PerSpecTM), in which large-throughput expression profiling of wild-type or hypomorphic mutants, depleted for essential targets, enables a computational strategy to address this challenge. We applied PerSpecTM to perform reference-based MOA prediction based on the principle that similar perturbations, whether chemical or genetic, will elicit similar transcriptional responses. Using this approach, we elucidated the MOAs of three molecules with activity against Pseudomonas aeruginosa by comparing their expression profiles to those of a reference set of antimicrobial compounds with known MOAs. We also show that transcriptional responses to small-molecule inhibition resemble those resulting from genetic depletion of essential targets by clustered regularly interspaced short palindromic repeats interference (CRISPRi) by PerSpecTM, demonstrating proof of concept that correlations between expression profiles of small-molecule and genetic perturbations can facilitate MOA prediction when no chemical entities exist to serve as a reference. Empowered by PerSpecTM, this work lays the foundation for an unbiased, readily scalable, systematic reference-based strategy for MOA elucidation that could transform antibiotic discovery efforts.Keywords
All Related Versions
Funding Information
- HHS | NIH | National Institute of Allergy and Infectious Diseases (NIH-U19AI142780)
- HHS | NIH | National Institute of Allergy and Infectious Diseases (NIH-1K08AI148581)
This publication has 66 references indexed in Scilit:
- A Next Generation Connectivity Map: L1000 Platform and the First 1,000,000 ProfilesCell, 2017
- Reducing the Bottleneck in Discovery of Novel AntibioticsMicrobial Ecology, 2016
- Structural and Functional Characterization of the LPS Transporter LptDE from Gram-Negative PathogensStructure, 2016
- Beta-Lactam Antibiotics Induce a Lethal Malfunctioning of the Bacterial Cell Wall Synthesis MachineryCell, 2014
- Mechanism and inhibition of 1-deoxy-d-xylulose-5-phosphate reductoisomeraseBioorganic Chemistry, 2014
- Phenotypic Landscape of a Bacterial CellCell, 2011
- DNA Topoisomerases and Their Poisoning by Anticancer and Antibacterial DrugsChemistry & Biology, 2010
- The Hsp90 Inhibitor Radicicol Interacts with the ATP-Binding Pocket of Bacterial Sensor Kinase PhoQJournal of Molecular Biology, 2008
- Characterization of Variability in Large-Scale Gene Expression Data: Implications for Study DesignGenomics, 2002
- Inhibition of Folate Biosynthesis and Function as a Basis for Chemotherapy1965